These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30358104

  • 21. Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer.
    Usón Junior PLS, Callegaro-Filho D, Bugano DDG, Moura F, Maluf FC.
    J Gastrointest Cancer; 2018 Dec; 49(4):481-486. PubMed ID: 28924968
    [Abstract] [Full Text] [Related]

  • 22. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
    Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, Wang X, Gong Y, Wang W, Kong X.
    Int J Cancer; 2012 Aug 01; 131(3):683-91. PubMed ID: 21913185
    [Abstract] [Full Text] [Related]

  • 23. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.
    Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239
    [Abstract] [Full Text] [Related]

  • 24. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer.
    Yu Y, Tong Y, Zhong A, Wang Y, Lu R, Guo L.
    Medicine (Baltimore); 2020 Dec 24; 99(52):e23863. PubMed ID: 33350781
    [Abstract] [Full Text] [Related]

  • 25. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
    Murakami M, Nagai Y, Tenjin A, Tanaka Y.
    Endocr J; 2018 Jun 27; 65(6):639-643. PubMed ID: 29643268
    [Abstract] [Full Text] [Related]

  • 26. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
    Dong Z, Sun X, Xu J, Han X, Xing Z, Wang D, Ge J, Meng L, Xu X.
    Med Sci Monit; 2019 Oct 17; 25():7770-7783. PubMed ID: 31619663
    [Abstract] [Full Text] [Related]

  • 27. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q, Zhao YP, Yang YC, Li LJ, Long X, Han SM.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 17; 6(6):641-5. PubMed ID: 18086633
    [Abstract] [Full Text] [Related]

  • 28. Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients.
    Song JY, Chen MQ, Guo JH, Lian SF, Xu BH.
    Medicine (Baltimore); 2018 Jan 17; 97(4):e9707. PubMed ID: 29369199
    [Abstract] [Full Text] [Related]

  • 29. Plasma microRNA192 in combination with serum CA19-9 as non-invasive prognostic biomarker in periampullary carcinoma.
    Murali Manohar K, Sasikala M, Kvsrr Y, Sunil V, Talukdar R, Murthy H, Ramji C, Rao GV, Pradeep R, Reddy DN.
    Tumour Biol; 2017 Mar 17; 39(3):1010428317695018. PubMed ID: 28351309
    [Abstract] [Full Text] [Related]

  • 30. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.
    Huang T, Jiang SW, Qin L, Senkowski C, Lyle C, Terry K, Brower S, Chen H, Glasgow W, Wei Y, Li J.
    Int J Mol Sci; 2015 Jan 29; 16(2):2956-70. PubMed ID: 25642754
    [Abstract] [Full Text] [Related]

  • 31. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.
    Chen D, Wu X, Xia M, Wu F, Ding J, Jiao Y, Zhan Q, An F.
    Oncol Rep; 2017 Oct 29; 38(4):2182-2188. PubMed ID: 28849236
    [Abstract] [Full Text] [Related]

  • 32. Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer.
    Xu X, Xiao Y, Hong B, Hao B, Qian Y.
    Cancer Biomark; 2019 Oct 29; 25(3):251-257. PubMed ID: 31282407
    [Abstract] [Full Text] [Related]

  • 33. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
    Koopmann J, Rosenzweig CN, Zhang Z, Canto MI, Brown DA, Hunter M, Yeo C, Chan DW, Breit SN, Goggins M.
    Clin Cancer Res; 2006 Jan 15; 12(2):442-6. PubMed ID: 16428484
    [Abstract] [Full Text] [Related]

  • 34. Diagnosis of pancreatic cancer using ¹⁸F-FDG PET/CT and CA19-9 with SUVmax association to clinical characteristics.
    Sun Y, Duan Q, Wang S, Zeng Y, Wu R.
    J BUON; 2015 Jan 15; 20(2):452-9. PubMed ID: 26011335
    [Abstract] [Full Text] [Related]

  • 35. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar 15; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 36. Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.
    Kang CY, Wang J, Axell-House D, Soni P, Chu ML, Chipitsyna G, Sarosiek K, Sendecki J, Hyslop T, Al-Zoubi M, Yeo CJ, Arafat HA.
    J Gastrointest Surg; 2014 Jan 15; 18(1):7-15. PubMed ID: 24002763
    [Abstract] [Full Text] [Related]

  • 37. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC, Liang PC, Jan S, Yang CY, Tien YW, Wei SC, Wong JM, Chang YT.
    Pancreatology; 2014 Jan 15; 14(5):366-72. PubMed ID: 25278306
    [Abstract] [Full Text] [Related]

  • 38. Expression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer.
    Cai CY, Zhai LL, Wu Y, Tang ZG.
    Eur J Surg Oncol; 2015 Feb 15; 41(2):228-35. PubMed ID: 25434328
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
    Kuhlmann KF, van Till JW, Boermeester MA, de Reuver PR, Tzvetanova ID, Offerhaus GJ, Ten Kate FJ, Busch OR, van Gulik TM, Gouma DJ, Crawford HC.
    Cancer Epidemiol Biomarkers Prev; 2007 May 15; 16(5):886-91. PubMed ID: 17507610
    [Abstract] [Full Text] [Related]

  • 40. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T, Zhang X, Gao S, Jing F, Yang Y, Du L, Zheng G, Li P, Li C, Wang C.
    Oncotarget; 2016 Dec 20; 7(51):85551-85563. PubMed ID: 27888803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.